Company Overview:

Beam Therapeutics is committed to establishing the leading, fully integrated platform for precision genetic medicines. To achieve this vision, Beam has assembled a platform that includes a suite of gene editing and delivery technologies and is in the process of building internal manufacturing capabilities. Beam’s suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. This has the potential to enable a wide range of potential therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases.

Position Overview:

The Vice President of Market Access and Public Policy will lead the strategic development and execution of market access and public policy initiatives to ensure the successful launch and sustainable patient access of our innovative gene editing medicines in both ex vivo and in vivo applications. This team leader role requires a deep understanding of the reimbursement environment for medicines, has a strong strategic track record, and preferably some experience with policy shaping. The ideal candidate will have a proven track record in developing and implementing access strategies and engaging with key stakeholders, including government agencies, payers, and patient advocacy groups. Therapeutic experience in cell therapy or rare diseases and genetic medicines is preferred.

Responsibilities:

• Develop and execute comprehensive market access strategies to ensure optimal pricing, reimbursement, and market entry for our portfolio, with a strong focus on rare diseases.
• Shape and influence public policy to support favorable regulatory and legislative environments for our products. Monitor and analyze policy trends and advocate for policies that align with company goals.
• Build and maintain relationships with government officials, regulatory agencies, and industry associations to advance our legislative and regulatory priorities.
• Collaborate with internal and external stakeholders, including payers, providers, patient advocacy groups, and industry partners, to drive market access initiatives and support patient access to therapies.
• Work closely with other departments, including Commercial, Medical Affairs, Regulatory, and Legal, to align market access strategies with broader business objectives.
• Lead overall Market Access and Public Policy for Beam globally, with an initial focus on the US and major European Markets.

Qualifications:

• BS/BA degree in business or related discipline. Advanced degree in Public Health, Health Policy, Business Administration, or a related field preferred.
• 20 or more years experience within the pharmaceutical or biotechnology industries, 7 or more of which in market access leadership roles.
• Launch experienced strongly preferred (US and or global)
• Experience in public policy, or government affairs within the pharmaceutical or biotechnology industry, with a strong focus on rare diseases is highly preferred.
• In-depth knowledge of the healthcare system, pricing and reimbursement processes, billing and coding processes, and regulatory landscape. Experience in rare disease markets or cell and gene therapy is preferred.
• Established network within the healthcare industry, including government agencies, and payers
• Experience leading internal, remote and field based teams with a proven track record of successfully delivering results in a positive, collaborative and compliant way with the ability to inspire and develop talent.
• Strong analytical and strategic thinking abilities, with a proven track record of developing and implementing successful market access strategies.
• Excellent verbal and written communication skills, with the ability to effectively engage and influence a wide range of stakeholders.
• Travel: Willingness to travel domestically and internationally as needed (up to 25%) to meet with stakeholders and attend industry events.